That’s because CMS requires genome-sequencing tests to be federally approved, a process that lab scientists say is too costly and time consuming to be done for every patient.
There are 50 public labs in the U.S. that can sequence COVID-19 samples, but Kelly Wroblewski, director of infectious diseases at the Association of Public Health Laboratories, told Insider that she doesn’t know of any labs that have completed the validation process to get federal approval.
“The process of validating a next-generation sequencing test is burdensome,” Ms. Wroblewski said. “It takes a lot of time. It takes a lot of data. It takes a lot of resources. And the thing about the variants is that variants of concern and of interest are constantly changing, so you would have to do a whole validation every time you have a variant.”
The one exception, Ms. Wroblewski said, is if epidemiologists need to disclose a patient’s variant information during contact tracing.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
